IRWD - Ironwood Pharmaceuticals Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call Transcript

Ironwood Pharmaceuticals, Inc. (IRWD) Q1 2022 Earnings Conference Call May 5, 2022 08:30 ET Company Participants Matt Roache - Director, Investor Relations Tom McCourt - Chief Executive Officer Mike Shetzline - Chief Medical Officer Sravan Emany - Chief Financial Officer Conference Call Participants Hannah Monigatti - JPMorgan David Amsellem - Piper Sandler Tim Chiang - Northland Capital Markets Boris Peaker - Cowen and Company Presentation Operator Good morning. My name is Joseph and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood Pharmaceuticals First Quarter 2022 Investor Update Call. [Operator Instructions] Thank you. Matt Roache, Director of Investor Relations, you may begin your conference. Matt Roache Thank you, Joseph. Good morning and thanks for joining us for our first quarter 2022 investor update. Our press release issued this morning can be found on our website. Today’s call and accompanying slides

For further details see:

Ironwood Pharmaceuticals, Inc. (IRWD) CEO Tom McCourt on Q1 2022 Results - Earnings Call Transcript